CD8A and neoplasm: Firstly, treatment with an adenovirus encoding an adapter protein to redirect antiviral antibodies towards tumor cells delayed tumor growth and elicited NK cell-dependent CD8+ T cell responses in adenovirus-immunized mice [40].